XML 17 R9.htm IDEA: XBRL DOCUMENT v3.23.4
BORROWINGS
6 Months Ended
Mar. 31, 2023
Broker-Dealer [Abstract]  
BORROWINGS

NOTE 3 – BORROWINGS

 

Commercial Loan

 

On April 9, 2020, the Company received a loan from the Small Business Administration pursuant to the Paycheck Protection Program (PPP) in the principal amount of $48,750. The note bears interest at a variable rate of approximately 1% and matured in April 2022; and it is currently in default. Forgiveness for the loan was applied for and is pending. The principal amount of the loan was based on the consulting agreement salary between Nexion Biosciences, Inc., organized in the state of Florida (NBFL) (a related party) and the CEO.

 

 

Notes Payable

 

From time to time, the Company’s subsidiary, Genvor Inc., enters into unsecured notes payable with individual investors. Only Noteholder E (below) has security in the form of a personal guarantee by the CEO and prior consultant (Note 6). The terms of these notes are listed below. Several of the notes are convertible into shares of the Company’s common stock as detailed in the following schedule.

 

                 Balance 
                 Convertible 
         Interest   Loan   into 
Noteholder  Origination  Maturity  Rate   Balance   Shares (c) 
Noteholder A (a)  2019  12/31/2021   0%  $217,000    N/A 
Noteholder B (a)  3/19/2019  4/29/2019   0%   510,000    N/A 
Noteholder C (a)  3/1/2019  2/29/2020   18%   32,500    N/A 
Noteholder D (d)  4/29/2019  unspecified   0%   300,000    30,000 
Noteholder E (a)  8/1/2019  8/31/2019   0%   37,500     N/A  
Noteholder F (a)(b)  2/27/2020  4/30/2020   0%   2,500    5,000 
Noteholder G  8/3/2021  8/3/2023   10%   12,500    25,000 
Noteholder H  6/27/2022  6/27/2024   5%   300,000    1,000,000 
Noteholder I (c)  10/26/2022  12/31/2023   3%   50,000    400,000 
               1,462,000    1,460,000 
(d) Debt discount              (150,556)     
              $1,311,444      

 

(a)Past due at December 31, 2022
(b)Note is payable in a combination of $2,500 to $6,000 in cash and 5,000 to 15,000 share of common stock
(c)Convertible into common stock of the subsidiary, Genvor Inc.

 

The notes do not have default provisions except Noteholder B receives a default penalty of $10,000 each month the note goes unpaid.

 

Interest expense totaled $71,665 and $121,002, respectively, for the six months ended March 31, 2023, and 2022, including default penalties. Late fees totaled $60,000 and $60,000, respectively, for the six months ended March 31, 2023, and 2022.